MIAT and hepatocellular carcinoma: A recent study reported that the expression of lnc-MIAT was positively correlated with the expression of immune checkpoint molecules in HCC, including PD-1, PD-L1, and CTLA4, influencing the immune microenvironment of HCC [46].